A Multicentre Study on Features of the Gut Microbiota of Patients With Critical Chronic Diseases in China
NCT ID: NCT05638269
Last Updated: 2024-07-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
12000 participants
OBSERVATIONAL
2022-03-01
2025-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
the Study of the Association Between the Gut Microbiota and Central Serous Chorioretinopathy
NCT06527326
A Longitudinal Study to Explore the Impact of Gut Microbiome on Brain Health in Alzheimer's Disease
NCT06837272
Characteristics and Clinical Significance of Gut Microbiota in Patients With Monoclonal Gammopathy
NCT06690593
Multi-omics Database Construction of Healthy Korean Volunteers
NCT06183697
the Gut Microbiome and Metabolomics in Chronic Lower extreMities Threatening Ischemia
NCT06220994
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
disease group
no intervention
no intervention
Observational studies, no intervention
control group
no intervention
no intervention
Observational studies, no intervention
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
no intervention
Observational studies, no intervention
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. living in the province where the hospital is located in the last three years;
3. with a medical diagnosis of one of the target diseases;
4. willing to provide written informed consent.
Exclusion Criteria
2. with medical diagnoses of other serious illnesses;
3. with a history of bariatric surgery or intestinal resection, except for appendectomy；
4. individual who was treated with drugs in the preceding 1 month, including antibiotics, metformin, statins, acid inhibitor, probiotics, and probiotics; individuals having consumed yogurt more than 3 times in the preceding 1 month; heavy drinkers who have consumed more than 4 taels of liquor or 1000ml of beer; frequent alcohol consumers who have drunk per week in the last month.
18 Years
75 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Natural Science Foundation of China
OTHER_GOV
Zhujiang Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Yan He
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Yan He
Role: STUDY_CHAIR
Zhujiang Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Emergency General Hospital
Chaoyang, Beijing Municipality, China
The People's Hospital Of Nanchuan Chongqing
Nanchuan, Chongqing Municipality, China
YongChuan hospital of Chongqing Medical Univeristy
Yongchuan, Chongqing Municipality, China
Fujian Medical University Union Hospital
Fuzhou, Fujian, China
Fujian Provincial Hospital
Fuzhou, Fujian, China
Fujian Cancer Hospital
Fuzhou, Fujian, China
The First Hospital of Lanzhou University
Lanzhou, Gansu, China
Lanzhou University Second Hospital
Lanzhou, Gansu, China
The Sixth Affiliated Hospital of South China University of Technology (Foshan Nanhai District People's Hospital )
Foshan, Guangdong, China
The First Affiliated Hospital of Jinan University（Guangzhou Overseas Chinese Hospital ）
Guangzhou, Guangdong, China
The seventh Affiliated Hospital, Sun Yat-sen University
Shenzhen, Guangdong, China
Zhongshan City People's Hospital
Zhongshan, Guangdong, China
The Second Affiliated Hospital of Guangxi Medical University
Nanning, Guangxi, China
People's Hospital of Guangxi Zhuang Autonomous Region
Nanning, Guangxi, China
Wuzhou Red Cross Hospital
Tongliao, Guangxi, China
The Affiliated Cancer Hospital of Guizhou Medical University
Guiyang, Guizhou, China
The Affiliated Hospital of Guizhou Medical University
Guiyang, Guizhou, China
Hainan Traditional Chinese Medicine Hospital
Haikou, Hainan, China
Daqing People's Hospital（The Fifth Affiliated Hospital of Harbin Medical University）
Daqing, Heilongjiang, China
The First Affiliated Hospital of Harbin Medical University
Harbin, Heilongjiang, China
The Sixth Affiliated Hospital of Harbin Medical University
Harbin, Heilongjiang, China
Jixi Ji Mine Hospital
Jixi, Heilongjiang, China
Qiqihar Hospital of Traditional Chinese Medicine
Qiqihar, Heilongjiang, China
Luoyang Maternal and Child Health Hospital
Luoyang, Henan, China
Cancer Hospital, The First Affiliated Hospital, College of Clinical Medicine,Medical College of Henan University of Science and Technology
Luoyang, Henan, China
Shangqiu First People's Hospital
Shangqiu, Henan, China
Wuhan Mental Health Center
Wuhan, Hubei, China
Xiangyang Central Hospital
Xiangyang, Hubei, China
Nanzhang People's Hospital
Xianyang, Hubei, China
Zhuzhou Central Hospital
Zhuzhou, Hunan, China
Affiliated Hospital of Inner Mongolia Minzu University
Wuzhou, Inner Mongolia, China
Wuxi No.2 People's Hospital
Wuxi, Jiangsu, China
Affiliated Hospital of Jinggangshan University
Ji’an, Jiangxi, China
First Affiliated Hospital of Gannan Medical University
Ganzhou, Jiangx, China
The Second Affiliated Hospital of Nanchang University
Nanchang, Jiangx, China
Chang Zhi Yi Xue Yuan Fu Shu He Ji Yi Yuan
Changzhi, Shanxi, China
The Second Hospital of Shanxi Medical University
Taiyuan, Shanxi, China
The Hospital of Shanxi University of Chinese Medicine
Taiyuan, Shanxi, China
Xi'an People's Hospital (Xi'an Fourth Hospital)
Xi’an, Shanxi, China
The First Affiliated Hospital of Xi'an Medical University
Xi’an, Shanxi, China
The General Hospital of Western Theater Command PLA
Chengdu, Sichuan, China
Guang'an People's Hospital
Guang’an, Sichuan, China
The People's Hospital of Leshan
Leshan, Sichuan, China
Tianjin Binhai New Area Dagang Hospital
Binhai, Tianjin Municipality, China
Tianjing Medical University Cancer Institute & Hospital
Dayingmen, Tianjin Municipality, China
Tianjin Beichen Hospital
Guoyuan Xincun, Tianjin Municipality, China
The First People's Hospital of Kashgar Prefecture
Kashgar, Xinjiang Uygur Autonomous Region, China
First Affiliated Hospital of Kunming Medical University
Kunming, Yunnan, China
Qunjing Hospital of Traditional Chinese Medicine
Qujing, Yunnan, China
Hwa Mei Hospital,University of Chinese Academy of Sciences
Ningbo, Zhejiang, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Hui Xu
Role: primary
Wenming Wang
Role: primary
Xiaoli Zhang
Role: primary
Yingping Cao
Role: primary
Falin Chen
Role: primary
Yan Chen
Role: primary
Liqiong Yao
Role: primary
Gechong Yong
Role: primary
Tian Cai
Role: primary
Minmin Li
Role: primary
Zhaofan Luo
Role: primary
Kang Chen
Role: primary
Li Xie
Role: primary
Yulin Yuan
Role: primary
Minzhong Tang
Role: primary
Wei Wang
Role: primary
Hai Huang
Role: primary
Xiang Wu
Role: primary
Dejun Yun
Role: primary
Yingyu Jin
Role: primary
Haiyan Gao
Role: primary
Jinyu Yang
Role: primary
Wenxiu Liu
Role: primary
Zhanjun Zhang
Role: primary
Tao Jiang
Role: primary
Weibing Yin
Role: primary
Xiaoliang Zhou
Role: primary
Zhengjiang Cheng
Role: primary
Xuesheng Li
Role: primary
Zuiming Jiang
Role: primary
Guoli Liu
Role: primary
Hongyu Huang
Role: primary
Honghou Dai
Role: primary
Tianyu Zhong
Role: primary
Xiaozhong Wang
Role: primary
Jufen Ma
Role: primary
Kunping Guan
Role: primary
Yuanyuan Pan
Role: primary
Hongli Liu
Role: primary
Zhuo Li
Role: primary
Yuan Liu
Role: primary
Yuanjiu Xu
Role: primary
Yin Xiang
Role: primary
Heng Zhang
Role: primary
Li Ren
Role: primary
Kai Chen
Role: primary
Aimin Xu
Role: primary
Yong Duan
Role: primary
Fuxing Zhang
Role: primary
Yufeng Liao
Role: primary
References
Explore related publications, articles, or registry entries linked to this study.
He Y, Wu W, Zheng HM, Li P, McDonald D, Sheng HF, Chen MX, Chen ZH, Ji GY, Zheng ZD, Mujagond P, Chen XJ, Rong ZH, Chen P, Lyu LY, Wang X, Wu CB, Yu N, Xu YJ, Yin J, Raes J, Knight R, Ma WJ, Zhou HW. Regional variation limits applications of healthy gut microbiome reference ranges and disease models. Nat Med. 2018 Oct;24(10):1532-1535. doi: 10.1038/s41591-018-0164-x. Epub 2018 Aug 27.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CALM2101
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.